Cancer-associated thrombosis (CAT) is a common cause of death amongst the cancer population.
The pathophysiology of VTE includes general and biological risk factors, common to cancer and non-cancer patients, however in patients with malignancy there are an additional number of disease-specific factors, which render the pathogenesis unique11.
The incidence of VTE increases exponentially with the increase in presented risk factors.
- Agnelli, G. et al. Apixaban for the treatment of venous thromboembolism associated with cancer. N. Engl. J. Med. 2020;382:1599–1607
- Kushner, A., West, DO, W. P. & Pillarisetty, L. S. Virchow Triad. StatPearls (StatPearls Publishing, 2019).
Developed by EPG Health for Medthority. This content has been developed independently of the sponsors who have had no editorial input into the content. EPG Health received unrestricted educational funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.